PubMed · 2006 · 29 citations · 25 references
MedicineOncologySurgeryChemotherapyOncologic Nuclear MedicineTumor PathologyCancer StagingConcurrent ChemoradiationLocoregional Recurrence ManagementNasopharyngeal CancerRadiation TherapyTherapy Response AssessmentCurative TherapyDifferential Treatment ResponseLocoregional Therapy Response AssessmentOncologic Pet ImagingPet Response CriteriaPet-computed TomographyTherapy Response EvaluationTreatment Response Criteria
UNLABELLED: This prospective study compares the efficacies of whole-body (18)F-FDG PET and a conventional work-up (CWU) in evaluating the treatment response for patients with locoregional advanced nasopharyngeal carcinoma (NPC) after primary curative therapy and investigates the impact of PET on patient management. METHODS: Patients who had locoregional advanced NPC (stages III and IVa-b, staged by (18)F-FDG PET and CWU) and who had completed primary curative therapy for 3 mo were enrolled. The curative therapy consisted of concurrent chemoradiotherapy with or without induction chemotherapy. All of the patients also underwent (18)F-FDG PET and CWU to evaluate the response. The criteria for final diagnosis were based on pathology or subsequent follow-up for at least 6 mo. Rates of detection by (18)F-FDG PET and CWU and the impact on management were determined on site and patient bases, respectively. RESULTS: From January 2002 to August 2005, 131 patients with NPC were eligible, including 71 patients with stage III NPC (group A) and 60 patients with stage IVa-b NPC (group B). Twelve patients were proven to have residual tumors. (18)F-FDG PET had a higher overall sensitivity than CWU in group A (100% vs. 25%) and group B (91.7% vs. 58.3%). The overall specificity of PET was significantly higher than that of CWU in group B (97.6% vs. 91.7%; P = 0.019) but was slightly lower in group A (95.7% vs. 96.7%). The overall accuracy of PET also was significantly higher than that of CWU in group B (97.2% vs. 89.4%; P = 0.002) but was similar to that of CWU in group A (95.8% vs. 95.3%). PET resulted in management changes in 11 patients (15.4%; 11/71) in group A, with positive and negative impacts on 3 and 8 patients, respectively. In group B, the management of 26 of 60 patients (43%) was changed as a result of PET and included positive impacts on 23 patients and negative impacts on 3 patients. CONCLUSION: (18)F-FDG PET plays differential roles in patients with stage III NPC and stage IVa-b NPC after primary curative therapy. PET has higher sensitivity and specificity in evaluating the response and results in better management of patients with stage IVa-b NPC. PET has a less prominent impact on patient management but higher sensitivity in patients with stage III NPC.
25
Jin‐Ching Lin, Jian‐Sheng Jan, Chen‐Yi Hsu et al. · Journal of Clinical Oncology · 2003 · 773 citations
Anthony T.�C. Chan, P. Teo, Roger K.C. Ngan et al. · Journal of Clinical Oncology · 2002 · 482 citations
Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma
Peter M. L. Teo, W. H. Kwan, W. Y. Lee et al. · Cancer · 1996 · 217 citations · Full text
Medicine, Oncology, Metastasis +13